Humoral rejection of human organ transplants

Springer Seminars in Immunopathology

Volumn 25, Issue 2, 2003, Pages 119-140

  Michaels, Paul J ^a   Fishbein, Michael C ^b   Colvin, Robert B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HLA ANTIGEN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS;

ARTICLE; BIOPSY TECHNIQUE; CELLULAR IMMUNITY; CHRONIC DISEASE; DONOR; GENE FREQUENCY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PATHOLOGICAL ANATOMY; PLASMAPHERESIS; PRIORITY JOURNAL; SERODIAGNOSIS; T LYMPHOCYTE ACTIVATION;

ANTIBODY FORMATION; COMPLEMENT C4; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 0141575346     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0139-x     Document Type: Article

References (122)

1. Abe M, Kawai T, Futatsuyama K, et al (1997) Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 63: 1616
2. Aranda JM Jr, Scornik JC, Normann SJ, et al (2002) Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73: 907
3. Bach FH, Turman MA, Vercellotti GM, et al (1991) Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 23: 205
4. Baldwin WM 3rd, Samaniego-Picota M, Kasper EK, et al (1999) Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 68: 894
5. Behr TM, Feucht HE, Richter K, et al (1999) Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18: 904
6. Benzaquen LR, Nicholson-Weller A, Halperin JA (1994) Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179: 985
7. Bian H, Reed EF (1999) Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol 163: 1010
8. Blanchong CA, Chung EK, Rupert KL, et al (2001) Genetic, structural and functional diversities of human complement components C4 A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 1: 365
9. Bohmig GA, Exner M, Habicht A, et al (2002) Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13: 1091
10. Bohmig GA, Regele H, Exner M, et al (2001) C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 12: 2482
11. Bonnaud EN, Lewis NP, Masek MA, et al (1995) Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 14: 163
12. Busch GJ, Reynolds ES, Galvanek EG, et al (1971) Human renal allografts. The role of vascular injury in early graft failure. Medicine (Baltimore), 50: 29
13. Byrne GW, McCurry KR, Martin MJ, et al (1997) Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63: 149
14. Caple J, McMahon J, Myles J, et al (1995) Acute vascular (humoral) rejection in non-OKT3-treated cardiac transplants. Cardiovasc Pathol 4: 11
15. Cherry R, Nielsen H, Reed E, et al (1992) Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 11: 24, discussion 30
16. Collins AB, Schneeberger EE, Pascual MA, et al (1999) Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10: 2208
17. Colvin RB (1998) Renal transplant pathology. In: Jennette JC, et al (eds) Heptinstall's pathology of the kidney, Lippincott-Raven, Philadelphia, pp 1409-1540
18. Cotterell AH, Collins BH, Parker W, et al (1995) The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 60: 861
19. Crespo M, Pascual M, Tolkoff-Rubin N, et al (2001) Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 71: 652
20. Croker BP, Clapp WL, Abu Shamat AR, et al (1996) Macrophages and chronic renal allograft nephropathy. Kidney Int Suppl 57: S42
21. Czerska B, Hobbs RE, James KB, et al (1995) Clinical manifestations of acute vascular rejection in cardiac transplant recipients. J Heart Lung Transplant 14: S46
22. Dalmasso AP, Benson BA, Johnson JS, et al (2000) Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up- regulation of CD59 expression. J Immunol 164: 3764
23. Dalmasso AP, Vercellotti GM, Fischel RJ, et al (1992) Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 140: 1157
24. Delikouras A, Hayes M, Malde P, et al (2001) Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71: 599
25. Feucht HE, Felber E, Gokel MJ, et al (1991) Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86: 464
26. Feucht HE, Schneeberger H, Hillebrand G, et al (1993) Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43: 1333
27. Fredrich R, Toyoda M, Czer LS, et al (1999) The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67: 385
28. Grandaliano G, Gesualdo L, Ranieri E, et al (1997) Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 63: 414
29. Grattan MT, Moreno-Cabral CE, Starnes VA, et al (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261: 3561
30. Grimm PC, McKenna R, Nickerson P, et al (1999) Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 10: 1582
31. Haas M, Rather LE, Montgomery RA (2002) C4d staining of perioperative renal transplant biopsies. Transplantation 74: 711
32. Habicht A, Regele H, Exner M, et al (2002) A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection. Wien Klin Wochenschr 114: 945
33. Halloran PF, Schlaut J, Solez K, et al (1992) The significance of the anti-class I antibody response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53: 550
34. Halloran PF, Wadgymar A, Ritchie S, et al (1990) The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 49: 85
35. Hammond EH, Ensley RD, Yowell RL, et al (1991) Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc 23: 26
36. Hammond EH, Hansen JK, Spencer LS, et al (1993) Vascular rejection in cardiac transplantation: histologic, immunopathologic, and ultrastructural features. Cardiovasc Pathol 2: 21
37. Hammond EH, Wittwer CT, Greenwood J, et al (1990) Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation 50: 776
38. Hammond EH, Yowell RL, Nunoda S, et al (1989) Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8: 430
39. Hammond EH, Yowell RL, Price Gd, et al (1992) Vascular rejection and its relationship to allograft coronary disease. J Heart Lung Transplant 11: S111
40. Henry ML, Han LK, Orosz CG, et al (1990) Modification of xenograft hyperacute rejection via xenoantibody depletion. Transplant Proc 22: 1081
41. Herzenberg AM, Gill JS, Djurdjev O, et al (2002) C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 13: 234
42. Hess MW, Schwendinger MG, Eskelinen EL, et al (2000) Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21). Blood 95: 2617
43. Holzknecht ZE, Kuypers KL, Plummer TB, et al (2002) Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 91: 1135
44. Hosenpud JD (1999) Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 138: S469
45. Hosenpud JD, Everett JP, Morris TE, et al (1995) Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 92: 205
46. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11
47. Itescu S, Tung TC, Burke EM, et al (1998) An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients. Lancet 352: 263
48. Ito S, Camussi G, Tetta C, et al (1984) Hyperacute renal allograft rejection in the rabbit. Lab Invest 51: 148
49. Ivanyi B, Fahmy H, Brown H, et al (2000) Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol 31: 1129
50. Iwaki Y, Terasaki PI (1987) Primary nonfunction in human cadaver kidney transplantation: evidence for hidden hyperacute rejection. Clin Transplant 1: 125
51. Jeannet M, Pinn VW, Flax MH, et al (1970) Humoral antibodies in renal allotransplantation in man. N Engl J Med 282: 111
52. Jin YP, Singh RP, Du ZY, et al (2002) Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin- dependent manner. J Immunol 168: 5415
53. Jordan SC, Quartel AW, Czer LS, et al (1998) Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66: 800
54. Kajiwara I, Kawamura K, Takebayashi S (1996) An analysis of monocyte/macrophage subsets and granulocyte-macrophage colony-stimulating factor expression in renal allograft biopsies. Nephron 73: 536
55. Kasahara M, Kiuchi T, Takakura K, et al (1999) Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation 67: 568
56. Lagaaij EL, Cramer-Knijnenburg GF, Kemenade FJ van, et al (2001) Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 357: 33
57. Lan HY, Yang N, Brown FG, et al (1998) Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 66: 1465
58. Lau CL, Palmer SM, Posther KE, et al (2000) Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg 69: 1520
59. Lederer SR, Kluth-Pepper B, Schneeberger H, et al (2001) Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59: 334
60. Lee PC, Terasaki PI, Takemoto SK, et al (2002) All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74: 1192
61. Lin Y, Soares MP, Sato K, et al (1999) Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. J Immunol 163: 2850
62. Lones MA, Czer LS, Trento A, et al (1995) Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 14: 151
63. Loy TS, Bulatao IS, Darkow GV, et al (1993) Immunostaining of cardiac biopsy specimens in the diagnosis of acute vascular (humoral) rejection: a control study. J Heart Lung Transplant 12: 736
64. Luke PP, Scantlebury VP, Jordan ML, et al (2001) Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 72: 419
65. MacPherson GG, Christmas SE (1984) The role of the macrophage in cardiac allograft rejection in the rat. Immunol Rev 77: 143
66. Magil AB, Tinckam K (2003) Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int (in press)
67. Magro CM, Deng A, Pope-Harman A, et al (2002) Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation 74: 1273
68. Manez R, Kelly RH, Kobayashi M, et al (1995) Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology 21: 1345
69. Matsushita M, Kuraya M, Hamasaki N, et al (2002) Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 168: 3502
70. Mauiyyedi S, Colvin RB (2002) Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11: 609
71. Mauiyyedi S, Crespo M, Collins AB, et al (2002) Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13: 779
72. Mauiyyedi S, Nelson C, N. T-R, Cosimi AB, et al (2000) Peritubular capillary lamination: a marker of antibody mediated chronic rejection of renal allografts. Mod Pathol 13: 176A
73. Mauiyyedi S, Pelle PD, Saidman S, et al (2001) Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12: 574
74. McCarthy JF, Cook DJ, Smedira NG, et al (1999) Vascular rejection in cardiac transplantation. Transplant Proc 31: 160
75. McCurry KR, Parker W, Cotterell AH, et al (1997) Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 58: 91
76. Michaels PJ, Espejo ML, Kobashigawa J, et al (2003) Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22: 58
77. Miller LW, Wesp A, Jennison SH, et al (1993) Vascular rejection in heart transplant recipients. J Heart Lung Transplant 12: S147
78. Monga G, Mazzucco G, Messina M, et al (1992) Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens. Mod Pathol 5: 125
79. Nickeleit V, Zeiler M, Gudat F, et al (2002) Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 13: 242
80. Olsen SL, Wagoner LE, Hammond EH, et al (1993) Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant 12: S135
81. Onitsuka S, Yamaguchi Y, Tanabe K, et al (1999) Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection. Clin Transplant 13 Suppl 1: 33
82. Palmer A, Taube DJ, Welsh K, et al (1989) Successful removal of anti-HLA antibodies by extrcorporeal immunoadsorption allowing renal transplantation. Lancet I: 10
83. Pascual M, Saidman S, Tolkoff-Rubin N, et al (1998) Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 66: 1460
84. Pei R, Lee JH, Shih NJ, et al (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75: 43
85. Petrossian GA, Nichols AB, Marboe CC, et al (1989) Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 80: III 122
86. Pisani BA, Mullen GM, Malinowska K, et al (1999) Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 18: 701
87. Platt JL (2002) C4d and the fate of organ allografts. J Am Soc Nephrol 13: 2417
88. Plissonnier D, Henaff M, Poncet P, et al (2000) Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 69: 2601
89. Racusen LC, Solez K, Colvin RB (2003) Antibody-mediated rejection criteria and biopsy classification - An addition to the Banff '97 classification. Am J Transplant (in press)
90. Reed EF, Hong B, Ho E, et al (1996) Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 61: 566
91. Regele H, Bohmig GA, Habicht A, et al (2002) Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 13: 2371
92. Regele H, Exner M, Watschinger B, et al (2001) Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16: 2058
93. Reznik SI, Jaramillo A, Zhang L, et al (2000) Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 119: 39
94. Rose EA, Pepino P, Barr ML, et al (1992) Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 11: S120
95. Rose EA, Smith CR, Petrossian GA, et al (1989) Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 106: 203, discussion 207
96. Russell PS, Chase CM, Colvin RB (1997) Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 64: 1531
97. Russel PS, Chase CM, Sykes M, Ito H, Shaffer J, Colvin RB (2001) Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 167: 5731
98. Salama AD, Delikouras A, Pusey CD, et al (2001) Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant 1: 260
99. Satake M, Kawagishi N, Rydberg L et al (1994) Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters: Main antibody reactivity against alpha-linked galactose-containing epitopes. Xenotransplantation 1: 89
100. Sawada T, Fuchinoue S, Teraoka S (2002) Successful Al-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 74: 1207
101. Sayegh M, Colvin RB (2003) Case records of the Massachusetts General Hospital. N Engl J Med (in press)
102. Schmoeckel M, Bhatti FN, Zaidi A, et al (1998) Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65: 1570
103. Shimizu A, Colvin RB, Yamanaka N (2000) Rejection of peritubular capillaries in renal allo- and xeno-grafts. Clin Transplant 14: 6
104. Shimizu A, Meehan SM, Kozlowski T, et al (2000) Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 80: 815
105. Shishido S, Asanuma H, Tajima E, et al (2001) ABO-incompatible living-donor kidney transplantation in children. Transplantation 72: 1037
106. Shushakova N, Skokowa J, Schulman J, et al (2002) C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 110: 1823
107. Smith RN, Kawai T, Boskovic S, et al (2003) Chronic humoral rejection in renal allografts in cynomolgus monkeys on mixed-chimerism: correlation of C4d, alloantibody and chronic allograft arteriopathy and glomerulopathy. Graft (in press)
108. Suciu-Foca N, Reed E, Marboe C, et al (1991) The role of anti-HLA antibodies in heart transplantation. Transplantation 51: 716
109. Sumitran S (2000) Clinical importance of HLA-specific and non-HLA-specific antibodies in allogeneic kidney transplantation. Adv Nephrol Necker Hosp 30: 29
110. Takakura K, Kiuchi T, Kasahara M, et al (1999) Humoral immunity in acute cellular rejection after living-donor liver transplantation. Transplant Proc 31: 526
111. Taylor DO, Yowell RL, Kfoury AG, et al (2000) Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19: 518
112. Theruvath TP, Saidman SL, Mauiyyedi S, et al (2001) Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72: 77
113. Toyoda M, Petrosian A, Jordan SC (1999) Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 68: 1311
114. Trpkov K, Campbell P, Pazderka F, et al (1996) Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema. Transplantation 61: 1586
115. Van den Elsen JM, Martin A, Wong V, et al (2002) X-ray crystal structure of the C4d fragment of human complement component C4. J Mol Biol 322: 1103
116. VanBuskirk AM, Wakely ME, Sirak JH, et al (1998) Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 65: 1115
117. Vangerow B, Hecker JM, Lorenz R, et al (2001) C1-Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation 8: 266
118. Wagner CR, Morris TE, Shipley GD, et al (1993) Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest 92: 1269
119. West LJ, Pollock-Barziv SM, Dipchand AI, et al (2001) ABO-incompatible heart transplantation in infants. N Engl J Med 344: 793
120. Williams GM, Hume DM, Huson RP Jr, et al (1968) "Hyperacute" renal-homograft rejection in man. N Eng J Med 279: 611
121. Yamakawa M, Imai Y (1992) Complement activation in the follicular light zone of human lymphoid tissues. Immunology 76: 378
122. Yard B, Spruyt-Gerritse M, Claas F, et al (1993) The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 55: 1287